431 related articles for article (PubMed ID: 25211026)
1. Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity.
Katorcha E; Makarava N; Savtchenko R; D'Azzo A; Baskakov IV
PLoS Pathog; 2014 Sep; 10(9):e1004366. PubMed ID: 25211026
[TBL] [Abstract][Full Text] [Related]
2. Sialylation Controls Prion Fate
Srivastava S; Katorcha E; Daus ML; Lasch P; Beekes M; Baskakov IV
J Biol Chem; 2017 Feb; 292(6):2359-2368. PubMed ID: 27998976
[TBL] [Abstract][Full Text] [Related]
3. Sialylation of the prion protein glycans controls prion replication rate and glycoform ratio.
Katorcha E; Makarava N; Savtchenko R; Baskakov IV
Sci Rep; 2015 Nov; 5():16912. PubMed ID: 26576925
[TBL] [Abstract][Full Text] [Related]
4. Reversible off and on switching of prion infectivity via removing and reinstalling prion sialylation.
Katorcha E; Daus ML; Gonzalez-Montalban N; Makarava N; Lasch P; Beekes M; Baskakov IV
Sci Rep; 2016 Sep; 6():33119. PubMed ID: 27609323
[TBL] [Abstract][Full Text] [Related]
5. Region-Specific Sialylation Pattern of Prion Strains Provides Novel Insight into Prion Neurotropism.
Makarava N; Chang JC; Baskakov IV
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012886
[TBL] [Abstract][Full Text] [Related]
6. Post-conversion sialylation of prions in lymphoid tissues.
Srivastava S; Makarava N; Katorcha E; Savtchenko R; Brossmer R; Baskakov IV
Proc Natl Acad Sci U S A; 2015 Dec; 112(48):E6654-62. PubMed ID: 26627256
[TBL] [Abstract][Full Text] [Related]
7. Assessment of strain-specific PrP(Sc) elongation rates revealed a transformation of PrP(Sc) properties during protein misfolding cyclic amplification.
Gonzalez-Montalban N; Baskakov IV
PLoS One; 2012; 7(7):e41210. PubMed ID: 22815972
[TBL] [Abstract][Full Text] [Related]
8. Role of sialylation of N-linked glycans in prion pathogenesis.
Makarava N; Baskakov IV
Cell Tissue Res; 2023 Apr; 392(1):201-214. PubMed ID: 35088180
[TBL] [Abstract][Full Text] [Related]
9. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
[TBL] [Abstract][Full Text] [Related]
10. Highly efficient protein misfolding cyclic amplification.
Gonzalez-Montalban N; Makarava N; Ostapchenko VG; Savtchenk R; Alexeeva I; Rohwer RG; Baskakov IV
PLoS Pathog; 2011 Feb; 7(2):e1001277. PubMed ID: 21347353
[TBL] [Abstract][Full Text] [Related]
11. Loss of Cellular Sialidases Does Not Affect the Sialylation Status of the Prion Protein but Increases the Amounts of Its Proteolytic Fragment C1.
Katorcha E; Klimova N; Makarava N; Savtchenko R; Pan X; Annunziata I; Takahashi K; Miyagi T; Pshezhetsky AV; d'Azzo A; Baskakov IV
PLoS One; 2015; 10(11):e0143218. PubMed ID: 26569607
[TBL] [Abstract][Full Text] [Related]
12. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
13. Methods of Protein Misfolding Cyclic Amplification.
Makarava N; Savtchenko R; Baskakov IV
Methods Mol Biol; 2017; 1658():169-183. PubMed ID: 28861790
[TBL] [Abstract][Full Text] [Related]
14. [Mechanisms of prion transmission].
Sakaguchi S
Nihon Rinsho; 2007 Aug; 65(8):1391-5. PubMed ID: 17695274
[TBL] [Abstract][Full Text] [Related]
15. Thermostability as a highly dependent prion strain feature.
Marín-Moreno A; Aguilar-Calvo P; Moudjou M; Espinosa JC; Béringue V; Torres JM
Sci Rep; 2019 Aug; 9(1):11396. PubMed ID: 31388046
[TBL] [Abstract][Full Text] [Related]
16. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
[TBL] [Abstract][Full Text] [Related]
17. Role of sialylation in prion disease pathogenesis and prion structure.
Baskakov IV
Prog Mol Biol Transl Sci; 2020; 175():31-52. PubMed ID: 32958238
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
19. Prion protein aggregation and fibrillogenesis in vitro.
Stöhr J
Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001
[TBL] [Abstract][Full Text] [Related]
20. Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.
Singh J; Udgaonkar JB
Biochemistry; 2015 Jul; 54(29):4431-42. PubMed ID: 26171558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
